Omeros Corporation
OMER
#6443
Rank
HK$5.98 B
Marketcap
HK$84.46
Share price
-1.63%
Change (1 day)
-7.10%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2025 (TTM): -HK$0.99 Billion

According to Omeros Corporation's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$1.23 Billion a decrease over its 2023 earnings that were of -HK$1.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.99 Billion-20.06%
2024 -HK$1.23 Billion9.63%
2023 -HK$1.13 Billion-9.57%
2022 -HK$1.25 Billion-30.65%
2021 -HK$1.79 Billion86.28%
2020 -HK$0.97 Billion99.45%
2019 -HK$0.49 Billion-49.91%
2018 -HK$0.97 Billion190.77%
2017 -HK$0.34 Billion-27.96%
2016 -HK$0.46 Billion-17.61%
2015 -HK$0.56 Billion1.88%
2014 -HK$0.55 Billion87.56%
2013 -HK$0.3 Billion
2011 -HK$0.22 Billion-8.96%
2010 -HK$0.24 Billion45.03%
2009 -HK$0.17 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-HK$73.87 Million-92.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-HK$30.09 Million-96.94%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
HK$92.26 B-9,490.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.19 B-25,768.33%๐Ÿ‡บ๐Ÿ‡ธ USA